Proton beam therapy versus stereotactic body radiotherapy for hepatocellular carcinoma: practice patterns, outcomes, and the effect of biologically effective dose escalation.
07/10/2019
/
Publications
With the National Cancer Database for T1-2N0 HCC patients receiving PBT or SBRT, a total of 71 patients received PBT and 918 patients received SBRT were...
A comparison of the outcomes between surgical resection and proton beam therapy for single primary hepatocellular carcinoma.
07/10/2019
/
Publications
There were 314 and 31 patients with single primary nodular HCC ≤ 100 mm without vessel invasion who underwent surgical resection (SR) and PBT were analyzed. The...
Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival.
07/01/2019
/
Publications
Published in the Red Journal, this single-institution retrospective study compared clinical outcomes of proton versus photon ablative radiation therapy in...
Extreme hypofractionated proton radiotherapy for prostate cancer using pencil beam scanning: Dosimetry, acute toxicity and preliminary results.
07/09/2019
/
Publications
/
Hypofractionation
Pencil Beam Scanning - PBS
A study by the research group in Prague. Two hundred patients with early-stage prostate cancer were treated with IMPT on extreme hypofractionated schedule (36...
Comparative toxicity outcomes of PBT vs IMRT for prostate cancer in the postoperative setting.
07/09/2019
/
Publications
/
Toxicity
A case-matched cohort analysis study compared acute and late genitourinary (GU) and gastrointestinal (GI) toxicity outcomes in patients with prostate cancer (PC...
A Comparison of Patient-Reported Health-Related Quality of Life During Proton Versus Photon Chemoradiotherapy for Esophageal Cancer.
07/07/2019
/
Publications
/
Quality of life
This study by Mayo Clinic aimed to compare Functional Assessment of Cancer Therapy - Esophagus (FACT-E) questionnaire changes during proton (PRT) or photon (XRT...
Clinical Results of Proton Beam Therapy for Esophageal Cancer
07/07/2019
/
Publications
A large retrospective study of 202 patients (90 inoperable patients and 100 patients (49.5%) had stage III/IV cancer) who were treated with PBT in Japan. This...
Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancer.
03/04/2019
/
Publications
/
Chemotherapy
A study by the Tsukuba group in Japan repored outcomes of 42 unresectable locally advanced pancreatic cancer patients treated with PBT and concurrent...
Proton Radiotherapy for Isolated Local Recurrence of Primary Resected Pancreatic Ductal Adenocarcinoma.
03/05/2019
/
Publications
This study by the Hyogo group in Japan analyzed 30 patients who had initially undergone surgery but isolated local recurrence occurred. PBT was administered...
Early and late side effects, dosimetric parameters and QoL after PBT and IMRT for prostate cancer
03/03/2019
/
Publications
/
Dosimetry
A study by the researchers of Dresden and Heidelberg. Eighty-eight patients with localized prostate cancer treated with PBT (31) or IMRT (57) were matched using...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.